|
|
Other links at Articles > Neurology and Neurosurgery |
| 2. |
FTY720 (Fingolimod) for Relapsing Multiple Sclerosis
|
|
|
A recent Phase II study has demonstrated that oral FTY720 is effective in reducing disease activity in relapsing multiple sclerosis with a favorable adverse-effect profile. These results are awaiting confirmation in the three ongoing Phase III clinical trials
Expert Review of Neurotherapeutics
|
| 3. |
Evaluating New Data for the Treatment of MS
|
|
|
This summary presents an overview of exciting new data on new and emerging pharmacologic treatments for multiple sclerosis presented at the 2007 ECTRIMS meeting. Medscape Neurology & Neurosurgery
|
| 5. |
Noninvasive Method Tracks Nerve Cell Development in Living Human Brain
|
|
|
Investigators have identified the first biomarker that allows them to noninvasively detect and track neural stem and progenitor cells in the living human brain — a finding that could lead to significantly better diagnosis, prognosis, and treatment of brain tumors as well as a range of neurological and psychiatric disorders. Medscape Medical News
|
|
|